About Volition
Volition is a company based in Gembloux (Belgium) founded in 1995. It operates as a HealthTech, and Professional Services. The company has 85 employees as of December 31, 2024. Volition has completed 1 acquisition, including Octamer. Volition offers products and services including Nu.Q® NETs, Nu.Q® Vet Cancer Test, Nu.Q® Discover, and Nu.Q® Cancer. Volition operates in a competitive market with competitors including Guardant Health, GRAIL, Color, Delfi Diagnostics and BillionToOne, among others.
- Headquarter Gembloux, Belgium
- Employees 85 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Volitionrx Limited
-
Annual Revenue
$1.23 M59.1as on Dec 31, 2024
-
Net Profit
$-26.97 M23.65as on Dec 31, 2024
-
EBITDA
$-25.72 M25.61as on Dec 31, 2024
-
Latest Funding Round
$16.25 M (USD), Post-IPO
May 20, 2025
-
Investors
Belgium
& 1 more
-
Employee Count
85
as on Dec 31, 2024
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Volition
Volition is a publicly listed company on the AMEX with ticker symbol VNRX in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Volition
Volition offers a comprehensive portfolio of products and services, including Nu.Q® NETs, Nu.Q® Vet Cancer Test, Nu.Q® Discover, and Nu.Q® Cancer. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
A CE-marked test for detecting NETosis in patients.
Blood test for detecting cancer in dogs affordably.
Assays for epigenetic profiling in drug development studies.
Blood-based assays for cancer detection and beyond.
Unlock access to complete
Unlock access to complete
Software Development Team
12 people
Leadership Team
11 people
Product Management Team
5 people
Scientist Team
3 people
Sales and Marketing
3 people
Human Resources and Administration
2 people
Legal and Compliance
2 people
Chairman Team
1 people
Unlock access to complete
Funding Insights of Volition
- Total Funding Total Funding
- Total Rounds 12
- Last Round Post-IPO — $16.2M
-
First Round
First Round
(25 Jul 2012)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May, 2025 | Amount | Post-IPO - Volition | Valuation |
investors |
|
| Mar, 2024 | Amount | Post-IPO - Volition | Valuation |
investors |
|
| Dec, 2023 | Amount | Post-IPO - Volition | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Volition
Volition has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Belgium and Wallonie Entreprendre. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
Official Belgian government information and services are provided online.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Volition
Volition has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Octamer. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Provider of screening substrates for epigenetics research
|
2018 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Volition
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Volition Comparisons
Competitors of Volition
Volition operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Guardant Health, GRAIL, Color, Delfi Diagnostics and BillionToOne, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Digital sequencing technology for cancer detection is developed.
|
|
| domain | founded_year | HQ Location |
Circulating tumor DNA is screened for early cancer detection.
|
|
| domain | founded_year | HQ Location |
Cancer care is delivered through a virtual clinic by Color.
|
|
| domain | founded_year | HQ Location |
Provider of DNA sequencing for cancer detection
|
|
| domain | founded_year | HQ Location |
Provider of cell-free cancer liquid biopsy test
|
|
| domain | founded_year | HQ Location |
Blood-based liquid biopsy tests for multiple cancer detection are provided.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Volition
Frequently Asked Questions about Volition
When was Volition founded?
Volition was founded in 1995 and raised its 1st funding round 17 years after it was founded.
Where is Volition located?
Volition is headquartered in Gembloux, Belgium. It is registered at Gembloux, Namur, Belgium.
Who is the current CEO of Volition?
Cameron Reynolds is the current CEO of Volition.
How many employees does Volition have?
As of Dec 31, 2024, the latest employee count at Volition is 85.
What is the annual revenue of Volition?
Annual revenue of Volition is $1.23M as on Dec 31, 2024.
What does Volition do?
Volition is engaged in advancing the science of epigenetics to revolutionize the diagnosis and monitoring of life-altering diseases such as cancer and sepsis. The company develops blood-based diagnostic tests using its proprietary Nu.Q technology, which detects characteristic epigenetic changes in nucleosomes from the earliest disease stages. Solutions are offered for human health, including NETosis detection, and veterinary applications like cancer screening in dogs. Additionally, research assays under the Nu.Q Discover program support drug development and clinical studies. Operating across multiple sectors, Volition collaborates globally with academic institutions and pharmaceutical companies from its offices in the USA, UK, Belgium, and Singapore.
Who are the top competitors of Volition?
Volition's top competitors include Guardant Health, GRAIL and BillionToOne.
What products or services does Volition offer?
Volition offers Nu.Q® NETs, Nu.Q® Vet Cancer Test, Nu.Q® Discover, and Nu.Q® Cancer.
Is Volition publicly traded?
Yes, Volition is publicly traded on AMEX under the ticker symbol VNRX.
How many acquisitions has Volition made?
Volition has made 1 acquisition, including Octamer.
Who are Volition's investors?
Volition has 2 investors. Key investors include Belgium, and Wallonie Entreprendre.
What is Volition's ticker symbol?
The ticker symbol of Volition is VNRX on AMEX.